Skip to main content
XRAYDENTSPLY SIRONA Inc.Sell4.6·$10.04-0.50%
Open full analysis

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis

Recovery setup

SellModerate Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Engine safety override at $10.04: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum.

Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, selling into approximately 140 countries through Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare... Read more

$10.04+20.2% A.UpsideScore 4.6/10#22 of 26 Medical Instruments & Supplies
QualityF-score8 / 9FCF yield6.41%
IncomeYield5.04%(5y avg 2.41%)Payout28.83%sustainable
Stop $9.33Target $12.06(analyst − 10%)A.R:R 2.1:1
Analyst target$13.40+33.5%15 analysts
$12.06our TP
$10.04price
$13.40mean
$9
$17

Sell if holding. Engine safety override at $10.04: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: Death cross but MACD improving, RSI 51. Score 4.6/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, earnings proximity 52d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

10-K grounded · weekly refresh

About DENTSPLY SIRONA Inc.

About DENTSPLY SIRONA Inc.

Dentsply Sirona's four reportable segments — Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare — encompass products including CEREC same-day restoration systems, the SureSmile clear aligner platform, and dental implant and continence care lines sold in approximately 140 countries. Henry Schein, Inc. represented 13% of net sales in 2025, making it the largest single distributor in a network through which roughly two-thirds of dental products flow. The company plans to increase R&D investment from approximately 4% to 5% of net sales beginning in 2026.

Dentsply Sirona earns revenue across all four operating segments. Connected Technology Solutions sells imaging equipment, treatment centers, CAD/CAM systems — primarily CEREC, which enables same-day restorations — and Primescan 2 intraoral scanners integrating with the cloud-based DS Core platform. Essential Dental Solutions provides endodontic files, sealers, composites, and preventive products to dental professionals. Orthodontic and Implant Solutions covers the SureSmile clear aligner platform, digital implant systems, and prosthetics. Wellspect Healthcare sells urinary catheters and bowel management systems primarily to medical supply distributors. The company generates a substantial portion of revenue through a limited number of distributors and is actively diversifying its U.S. distributor base beginning in 2026. Certain raw materials are sourced from single-source suppliers under agreements subject to periodic renewal; disruption of those sources could interrupt manufacturing.

Show full overview

EU Medical Device Regulation compliance is a named, dated regulatory obligation: Dentsply Sirona completed quality management system certifications in 2024, but Class III and implantable Class IIb devices must achieve EU MDR certification by December 31, 2027 and non-implantable Class IIb and lower-risk devices by December 31, 2028. A simultaneous execution risk is the 2026 restructuring plan — expected to incur $55 million to $65 million in charges and generate approximately $120 million in annualized savings — running concurrently with a multi-year global ERP system implementation begun in 2023. Cost overruns or delays in either program could adversely affect results of operations.

See also: Healthcare · Medical Instruments & Supplies

From DENTSPLY SIRONA Inc.'s most recent 10-K filing, extracted June 16, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15

Recent Developments — DENTSPLY SIRONA Inc.

Generated 2026-06-17T09:02:28Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202652d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.5 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)6.5
Mkt Cap$2.0B
EV/EBITDA7.5
Profit Mgn-17.1%
ROE-37.7%
Rev Growth0.1%
Beta0.91
Dividend5.04%
Rating analysts22

Quality Signals

Piotroski F8/9

Options Flow

P/C0.75neutral
IV55%elevated
Max Pain$3-75.1% vs spot

Concentration Risks(10-K Item 1A)

  • LOWCustomerHenry Schein, Inc.13%
    10-K Item 1: 'Henry Schein, Inc. ... 13 | %'

Material Events(8-K, last 90d)

  • 2026-02-24Item 5.02LOW
    Board increased from 11 to 13 directors; James D. Forbes and Brian P. McKeon appointed effective February 27, 2026. Forbes to Compensation & Human Capital Committee; McKeon to Audit/Finance and Science & Technology Committees. Routine board expansion; no officer departures.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

5 floor-breakers·1 ceiling hit

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
2.5
Low model confidence on this dimension (33%).

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.6
Growth Rank
0.8
Value Rank
9.6

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Volume
0.0
Obv
1.0
Ma Position
4.0
Rsi
4.5
Macd
7.4
Volume distribution (falling OBV)Below 200-MA, MA slope -4.7%/30d — confirmed downtrend

Unprofitable operations — net margin -17.1%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Operating Margin
1.4
Roa
1.5
Moat
3.9
Fcf Quality
4.7
Current Ratio
5.6
Gross Margin
5.8
Piotroski F
8.9
FCF-positive but moderate margins (FCF margin 4%, FCF yield 6.4%)No competitive moatStrong Piotroski F-Score: 8/9

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
0.0
Earnings History
1.1
Erm
5.0
Earnings Timing
5.0
News Activity
5.0
Dividend Safety
7.0
Earnings concerns: 1B/2MDividend: 504.0%
GatesMomentum 3.4<4.5Death cross (50MA < 200MA)Executive change: officer departure/appointmentA.R:R 2.1 ≥ 1.5Insider activity: OKEARNINGS PROXIMITY 52d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
51 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $9.40Resistance $10.67

Price Targets

$9
$12
A.Upside+20.1%
A.R:R2.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.5 < 4.0)
! momentum at 3.4 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-08-06 (52d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is XRAY stock a buy right now?

Sell if holding. Engine safety override at $10.04: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality; Negative price momentum. Chart setup: Death cross but MACD improving, RSI 51. Prior stop was $9.33. Score 4.6/10, moderate confidence.

What is the XRAY stock price target?

Take-profit target: $12.06 (+20.2% upside). Prior stop was $9.33. Stop-loss: $9.33.

What are the risks of investing in XRAY?

Quality below floor (3.5 < 4.0).

Is XRAY overvalued or undervalued?

DENTSPLY SIRONA Inc. trades at a P/E of N/A (forward 6.5). TrendMatrix value score: 8.7/10. Verdict: Sell.

What do analysts say about XRAY?

22 analysts cover XRAY with a consensus score of 3.4/5. Average price target: $13.

What does DENTSPLY SIRONA Inc. do?Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, selling into...

Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, selling into approximately 140 countries through Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare segments. Revenue comes from equipment, consumables, software, and continence care products; Henry Schein accounted for 13% of 2025 net sales.

Related stocks: NVST (Envista Holdings Corporation) · LMAT (LeMaitre Vascular, Inc.) · MMED (MiniMed Group, Inc.) · MMSI (Merit Medical Systems, Inc.) · TFX (Teleflex Incorporated)
Home Stocks XRAY

Latest news

Latest News

Benzinga6d agoLeadership Change
Benzinga19d agoAnalyst
Benzinga22d ago
Benzinga42d agoAnalyst
Benzinga42d agoEarnings
Benzinga43d agoEarnings
Benzinga43d agoEarnings
Benzinga43d agoEarnings
Benzinga44d agoProduct
Benzinga63d ago